X
CLOV icon

Xponance’s Clover Health Investments CLOV Stock Holding History

Xponance’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Buy
36,915
+4,900
+15% +$10.6K ﹤0.01% 1612
2025
Q4 		$75.2K Buy
32,015
+599
+2% +$1.64K ﹤0.01% 1492
2025
Q3 		$96.1K Buy
31,416
+274
+0.9% +$783 ﹤0.01% 1446
2025
Q2 		$86.9K Buy
+31,142
New +$102K ﹤0.01% 1423
2023
Q2 		– Sell
-22,047
Closed -$18.6K – 1265
2023
Q1 		$18.6K Hold
22,047
– – ﹤0.01% 1218
2022
Q4 		$20.5K Buy
22,047
+219
+1% +$292 ﹤0.01% 1216
2022
Q3 		$37K Buy
21,828
+1,266
+6% +$3.32K ﹤0.01% 1159
2022
Q2 		$44K Buy
+20,562
New +$54.6K ﹤0.01% 1163

Other funds holding CLOV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return